Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 1997

View Archived Issues

Orally active antithrombotic agents described by Pfizer

Improved dolastatin derivatives prepared by BASF

Univ. of Pittsburgh claims inhibitors of farnesyltransferase/geranylgeranyltransferase

Thrombin inhibitors from Akzo Nobel

MS&D reports another series of potent and selective 5-HT1D agonists

Hoechst reveals new Na+/H+ exchange inhibitors

Kyowa Hakko discloses new calcitonin derivatives

Novel semisynthetic macrolides from Abbott

SKB discovers first selective human 5-HT1B receptor ligand

Novel anxiolytic and antidepressant buspirone analogue characterized

MDR-reversing agent from Mitsui Toatsu characterized in vitro and in vivo

FDA approves Hemagen Diagnostics' test for primary biliary cirrhosis

Cytel and Baxter enter research agreement for the development of ex vivo cancer therapy

Preclinical profile of MDL-27192

OrthoLogic and Sanofi to market sodium hyaluronate for osteoarthritis knee pain in the U.S.

Update on new injectable streptogramin antibiotic

Phase II results with Immunex's Flt3 ligand reported

NDA for entacapone scheduled for submission this month

Seikagaku's SOD preparation enters clinic in Europe

BMS to comarket antiemetic azasetron in Japan

More news on resveratrol

Lidak reports promising phase I/II data with melanoma vaccine

Baxter's DCLHb safe in acute ischemic stroke patients

Cambridge NeuroScience suspends phase III trial of Cerestat following interim data analysis

Novopharm Biotech issued U.S. patent for two human monoclonal antibodies

PEG-rHuMGDF enhances platelet recovery in cancer patients undergoing chemotherapy

Advisory committee recommends Taxol for KS

Agouron's acquisition of Alanex final

Meridian and Genpharm sign marketing agreement

BioSpecifics Technologies and Bausch & Lomb collaborate on glaucoma studies

IDEC and SmithKline Beecham suspend rheumatoid arthritis trial

New indication for enoxaparin recommended for approval

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...